Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models
Grünewald, Sylvia, Politz, Oliver, Bender, Sebastian, Héroult, Mélanie, Lustig, Klemens, Thuss, Uwe, Kneip, Christoph, Kopitz, Charlotte, Zopf, Dieter, Collin, Marie-Pierre, Boemer, Ulf, Ince, Stuart,Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.32224
Date:
February, 2019
File:
PDF, 2.06 MB
english, 2019